HomeCompareCAUUF vs ARCC

CAUUF vs ARCC: Dividend Comparison 2026

CAUUF yields 5.25% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARCC wins by $3.9K in total portfolio value
10 years
CAUUF
CAUUF
● Live price
5.25%
Share price
$0.38
Annual div
$0.02
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$0.54
Full CAUUF calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — CAUUF vs ARCC

📍 ARCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAUUFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAUUF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAUUF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAUUF
Annual income on $10K today (after 15% tax)
$446.19/yr
After 10yr DRIP, annual income (after tax)
$0.46/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, ARCC beats the other by $0.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAUUF + ARCC for your $10,000?

CAUUF: 50%ARCC: 50%
100% ARCC50/50100% CAUUF
Portfolio after 10yr
$22.5K
Annual income
$0.84/yr
Blended yield
0.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

CAUUF
No analyst data
Altman Z
4.1
Piotroski
4/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAUUF buys
0
ARCC buys
0
No recent congressional trades found for CAUUF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAUUFARCC
Forward yield5.25%10.65%
Annual dividend / share$0.02$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$20.6K$24.5K
Annual income after 10y$0.54$1.14
Total dividends collected$533.00$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CAUUF vs ARCC ($10,000, DRIP)

YearCAUUF PortfolioCAUUF Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$10,962$262.47$11,373$532.74$411.00ARCC
2$11,864$134.45$12,608$279.46$744.00ARCC
3$12,763$68.00$13,809$142.90$1.0KARCC
4$13,690$34.18$15,042$72.20$1.4KARCC
5$14,666$17.13$16,341$36.27$1.7KARCC
6$15,701$8.58$17,732$18.18$2.0KARCC
7$16,804$4.29$19,231$9.10$2.4KARCC
8$17,983$2.15$20,851$4.55$2.9KARCC
9$19,243$1.07$22,605$2.28$3.4KARCC
10$20,590$0.54$24,504$1.14$3.9KARCC

CAUUF vs ARCC: Complete Analysis 2026

CAUUFStock

Centaur Media Plc provides business information, training, and specialist consultancy to professional and commercial markets in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Xeim and The Lawyer. The company's marketing platform includes Econsultancy, Influencer Intelligence, MW Mini MBA, Festival of Marketing, Marketing Week, Design Week, Creative Review, Really B2B, Fashion & Beauty Monitor, Oystercatchers, and Foresight News. It also offers The Lawyer, which provides intelligence to legal market. Centaur Media Plc was incorporated in 2003 and is headquartered in London, the United Kingdom.

Full CAUUF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this CAUUF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAUUF vs SCHDCAUUF vs JEPICAUUF vs OCAUUF vs KOCAUUF vs MAINCAUUF vs HTGCCAUUF vs GBDCCAUUF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.